12 Distributors Signed for Remplir Covering 21 States in US
Filed with ASX · · 3 pages · English
Story so far
Earlier from Orthocell
- Remplir Approved to Commence Sales in US$75m Canadian Market
- Replacement Trading Halt
- Pause in Trading
- Remplir Approved to Commence Sales in US$84M Thai Market
- First US Distributors Signed for Remplirs US$1.6B market
Later from Orthocell
- Remplir Approved to Commence Sales in the Hong Kong Market
- Compelling Data Highlights Remplir Competitive Advantage
- First Surgical Use of Remplir in US$1.6 Billion US Market
- Record Revenue of $2.73m in June 25 Quarter up 22.8% QoQ
- Orthocell Announces First US Remplir Sales Revenue
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell